Riskpilot← Back to searchSign inGet full accessLarcombe Medical AB
ABActiveOrg 5593638009Haparandagatan 5Medical specialists activities · NACE 8622Est. 20220 employees
Revenue 2025
SEK 254K
-2% vs 2024
EBITDA margin
92.6%
-4% vs 2024
Equity ratio
65.8%
Financial strength
Net profit 2025
SEK 187K
-5% vs 2024
| Revenue | SEK 254K | -2% |
| EBITDA | SEK 235K | -4% |
| Net profit | SEK 187K | -5% |
| Total assets | SEK 323K | -18% |
| Equity | SEK 213K | -4% |
| Employees | 0 | — |
Legal name
Larcombe Medical AB
Org number
5593638009
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 februari 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkarmottagning, medicinska undersökningar, utredningar samt intyg. Rådgivning inom de medicinska områdena obstetrik, gynekologi samt mödrahälsovård. Bolaget skall även ta konsultuppdrag som läkare och föreläsare och därmed förenlig verksamhet. Företaget skall även äga och förvalta värdepapper.
Address
Haparandagatan 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 326 | 287 | 259 | 254 |
| Staff expenses | — | — | — | −4 |
| EBITDA | 294 | 254 | 246 | 235 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 294 | 254 | 246 | 235 |
| Net financials | — | 1 | 1 | 1 |
| Profit before tax | 294 | 256 | 247 | 236 |
| Tax | −60 | −52 | −51 | −48 |
| Net profit | 233 | 203 | 196 | 187 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 395 | 400 | 392 | 323 |
| Equity | 258 | 229 | 221 | 213 |
| Long-term debt | — | — | — | — |
| Short-term debt | 137 | 171 | 170 | 111 |
| Total debt | 137 | 171 | 170 | 111 |
EBITDA margin
92.6%
This company
15.8%
Market median
+486% vs market
20222025
Equity ratio
65.8%
This company
38.2%
Market median
+72% vs market
20222025
Return on equity
88.0%
This company
18.4%
Market median
+378% vs market
20222025
Net profit margin
73.8%
This company
8.1%
Market median
+811% vs market
20222025
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20222025
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-02 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AI Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Larcombe Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Ingrid Josefina Larcombe | Chief Executive Officer | 0 companies |
| Max Thomas Larcombe | Deputy Board Member | 0 companies |